BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 11042139)

  • 1. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
    Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
    J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
    Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
    FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
    De Petrocellis L; Melck D; Ueda N; Maurelli S; Kurahashi Y; Yamamoto S; Marino G; Di Marzo V
    Biochem Biophys Res Commun; 1997 Feb; 231(1):82-8. PubMed ID: 9070224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.
    Cravatt BF; Demarest K; Patricelli MP; Bracey MH; Giang DK; Martin BR; Lichtman AH
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9371-6. PubMed ID: 11470906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V; Bisogno T; De Petrocellis L; Brandi I; Jefferson RG; Winckler RL; Davis JB; Dasse O; Mahadevan A; Razdan RK; Martin BR
    Biochem Biophys Res Commun; 2001 Feb; 281(2):444-51. PubMed ID: 11181068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
    Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.
    Ford WR; Honan SA; White R; Hiley CR
    Br J Pharmacol; 2002 Mar; 135(5):1191-8. PubMed ID: 11877326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
    Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.
    Di Marzo V; Breivogel C; Bisogno T; Melck D; Patrick G; Tao Q; Szallasi A; Razdan RK; Martin BR
    Eur J Pharmacol; 2000 Oct; 406(3):363-74. PubMed ID: 11040343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid.
    Fowler CJ; Jonsson KO; Andersson A; Juntunen J; Järvinen T; Vandevoorde S; Lambert DM; Jerman JC; Smart D
    Biochem Pharmacol; 2003 Sep; 66(5):757-67. PubMed ID: 12948856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.